Striant Articles
J&J/Actavis recall US lots of fentanyl patches
25 February 2008
Solvay's 2007 income climbs just 1%
25 February 2008
Six-month Decapeptyl similar to present forms
18 February 2008
AGI begins dosing in Ph II CID trial
11 February 2008
FDA tightens warning on J&J's Ortho Evra patch
28 January 2008
ProStrakan's 2007 sales exceed expectations
21 January 2008
Japan stock market week to Nov 14
7 January 2008
Galvus gets positive opinion from CHMP
24 December 2007
KV reports record sales in 2nd-qtr fiscal 2008
10 December 2007
Ferring completes degarelix Ph III study
10 December 2007
Ardana's BPH drug effective with just two annual doses
26 November 2007
Watson's 3rd-qtr 2007 revenue hits $594.7M
19 November 2007
Indevus submits NDA for Nebido to US FDA
12 November 2007
Novartis' Exelon patch launched in the UK
29 October 2007
NovaQuest signs accord on ProStrakan's Sancuso
29 October 2007
Japan stock market week to Oct 22, 2007
29 October 2007
Pharmacopeia acquires B-MS' SARM program
22 October 2007
UCB's Neupro effective for motor impairment in PD
15 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Ardana's six-month loss widens to L6.9 million
15 October 2007
Exelon gets EC OK for Alzheimer's disease
1 October 2007
Onyvax begins Ph IIb trial of prostate cancer vacc
27 September 2007
Hewlett Packard out-licenses drug patch technology to Crospon
24 September 2007
ProStrakan's 1st-half revenues jump 28%
24 September 2007
IDEA licenses Diractin to Alpharma
17 September 2007
Shire orders limited recall of Daytrana patch
10 September 2007
Teverelix LA achieves 8-week suppression
10 September 2007
Japan stock market week to August 13, 2007
20 August 2007
ProStrakan out-licenses Sancuso in S Korea
20 August 2007
Vivus' 2nd-qtr loss grows 16% on Qnexa costs
13 August 2007
FDA clears EvaMist for menopause symptoms
6 August 2007
UCB's 1st-half profits fall 39% on Schwarz buy
6 August 2007
Stock Commentary - New York week to July 23, 2007
30 July 2007
CHMP recommends approval Exelon patch
30 July 2007
Japan stock market week to July 9, 2007
26 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Acrux delivers on male testosterone lotion
23 July 2007
Neupro patch for PD patients in the USA
23 July 2007
ProStrakan submits Sancuso MAA
23 July 2007
Stock Commentary - Europe - week to July 9, 2007
16 July 2007
Novartis progresses NM100060 using NexMed's NexACT
16 July 2007
ProStrakan's 1st-half 2007 sales jump 15%
16 July 2007
Ardana's fiscal 2007 loss per share widens 28.6%
9 July 2007
Solvay submits US sNDA for AndroGel
25 June 2007
Bradley Pharma debuts Elestrin in USA
18 June 2007
ProStrakan launches Tostran in the UK
18 June 2007
GSK returns rights to Futura Medical's ED gel
21 May 2007
Transdermal AD patch impresses in IDEAL trial
21 May 2007
SMC approves S-P's Remicade in psoriasis
21 May 2007
US FDA approves Schwarz' Neupro
14 May 2007
BioSante in contraceptive deal with Pantarhei
14 May 2007
Watson's 1st-qtr 2007 income leaps 26%
14 May 2007
Schwarz' sales drop 6.2% in 1st qtr of 2007
7 May 2007
Cimzia key drug in UCB 2007 R&D update
7 May 2007
Stock Commentary - New York week to April 2
9 April 2007
ProStrakan narrows 2006 loss to L18.3M
9 April 2007
KV pays initial $10M for US rights to EvaMist
9 April 2007
Strong data on Bayer's Testogel and Nebido
2 April 2007
Ipsen's FY 2006 sales rise 6.8% to $1.15B
26 March 2007
BioSante swings to $2.8M income in 2006
26 March 2007
Vivus' 4th-qtr 2006 net loss improves 20%
26 March 2007
Medical literature supports Bradley's low-dose estrogen
12 March 2007
Watson sees a 4th-qtr 2006 net loss of $489M
12 March 2007
GTx presents strong interim Ph II Acapodene data
5 March 2007
Strong Ph I data for Teverelix LA
26 February 2007
Ardana licenses Striant to TwinPharma
19 February 2007
France's Afssaps to review four drugs
29 January 2007
Neupro patch launched in UK for all stages of PD
29 January 2007
BioSante initiates Ph III trial of LibiGel
8 January 2007
Schwarz Pharma's rotigotine performs well in PD trial
8 January 2007
BioSante's Elestrina cleared in the USA
22 December 2006
Stock Commentary - Europe - week to Dec 11, 2006
18 December 2006
Vivus' EvaMist NDA accepted by US FDA
18 December 2006
ProStrakan and Ferring sign licensing deal
18 December 2006
Roche licenses Halozyme's Enhanze in deal worth upto $581M
11 December 2006
QLT
11 December 2006
ProStrakan buys Tostran and Rectogesic
4 December 2006
Strong Ph II data for AEterna Zentaris' ozarelix
20 November 2006
Shire's 3rd-qtr 2006 revenue rises 19%
6 November 2006
Schering and Organon end R&D collaboration
25 September 2006
ProStrakan half-year sales up 28% to L16.1M
25 September 2006
Acrux to start US trial of testosterone lotion
25 September 2006
Ardana reports promising results in trials of its testosterone cream
18 September 2006
EpiCept receives F&S Transdermal Drug Delivery award
28 August 2006
Mylan updates on fentanyl expectations
14 August 2006
Bentley reports 2nd-qtr 2006 EPS of $0.12
14 August 2006
Mylan sees record 1st-qtr 2007 revenues
7 August 2006
Phosphagenics initiates Ph I TPM-02/ Insulin trial
31 July 2006
Novartis' Exelon patch "better than tablet"
31 July 2006
Final appro for Mylan's Estradiol strengths
26 July 2006
CeNeS and Ergomed's revenue share deal
24 July 2006
Ardana's sees losses of L8.8 M in 2005/6
10 July 2006
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
